Target
albumin paclitaxel
8 abstracts
Abstract
Neoadjuvant immunochemotherapy and new radiomic predictor for resectable locally advanced oral squamous cell carcinoma.Org: Division of Head & Neck Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, China, State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China, State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Department of Head and Neck Oncology Surgery, West China Hospital of Stomatology, Sichuan University, Chengdu, China, State Key Laboratory of Oral Diseases and National Clinical Research Center for Oral Diseases and Department of Oral Pathology, West China Hospital of Stomatology, Sichuan University, Chengdu, China, State Key Laboratory of Oral Diseases and National Clinical Research Center for Oral Diseases and Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, China,
Abstract
Genomic and biomarker analysis of immunotherapy combined with chemotherapy treated for patients with metastatic BTC cancer: A real world study.Org: Chinese People's Liberation Army General Hospital, Chinese People’s Liberation Army General Hospital, Senior Department of Oncology, The 5th Medical Center of the PLA General Hospital,
Abstract
Combining nimotuzumab with PD-L1 inhibitors and chemotherapy to treat esophageal cancer: A retrospective study.Org: First Affiliated Hospital of Guangdong Pharmaceutical University,
Abstract
Efficacy and safety of camrelizumab combined with chemotherapy versus chemotherapy alone as preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma: Preliminary results from a multicenter, prospective, randomized controlled study.Org: The First Affiliated Hospital of Anhui Medical University, Hefei, China National Biotec Group, Fuyang Cancer Hospital, Anqing Municipal Hospital,
Abstract
Neoadjuvant immunochemotherapy for esophageal squamous cell carcinoma with camrelizumab, albumin-paclitaxel, carboplatin and apatinib (GASTO-1093): A single-arm, open-label, phase 2 trial.Org: Department of Thoracic Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, 1st Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, MD Anderson Cancer Center, Houston, TX, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, Department of Radiation Oncology, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China,
Abstract
Circulating levels of the pro-inflammatory monomeric isoform of C-reactive protein (mCRP) correlate with inflammatory markers in patients with stage II-III colon cancer.Org: Akershus University Hospital (Ahus), Sørlandet Hospital, University of Louisville,
Abstract
LDE-paclitaxel in second or later lines in advanced pancreatic cancer: A phase I trial.Org: Universidade Federal de São Paulo (UNIFESP), Instituto do Coração (INCOR-HCFMUSP) da Faculdade de Medicina e Escola de Farmácia da Universidade de São Paulo, Departamento de Medicina, Universidade Federal de São Paulo (UNIFESP),
Abstract
The effect of inflammatory-nutri̇tional prognosti̇c scori̇ng (INPS) system on treatment response and prognosi̇s i̇n pati̇ents wi̇th locally advanced gastroesophageal juncti̇on and gastri̇c cancer wi̇th neoadjuvant systemi̇c treatment.Org: Emory Winship Cancer Institute, Department of Engineering Sciences, Izmir Katip Celebi University, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Dokuz Eylul University Faculty of Medicine,